[Pharmacological studies on quinazoline-2, 4-dione derivaties,  H-27 and H-88: (1) anti-inflammatory, analgesic and antipyretic activities].
D000315:Adrenalectomy; D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001831:Body Temperature / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D002818:Cordotomy; D004353:Drug Evaluation, Preclinical; D004487:Edema / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy; D005260:Female; D006097:Granulation Tissue / Q000187:drug effects; D006461:Hemolysis / Q000187:drug effects; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D011799:Quinazolines / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D011817:Rabbits; D051381:Rats
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D011799:Quinazolines